S2212

Shorter Anthracycline-Free Chemo Immunotherapy Adapted to Pathological Response in Early Triple Negative Breast Cancer (SCARLET), A Randomized Phase III Study
Status:

Open

Trial Type:

Contact:

William Sikov, MD
wsikov@wihri.org
Stephanie Graff, MD
sgraff1@brownhealth.org